Quantbot Technologies LP Takeda Pharmaceutical CO LTD Transaction History

Quantbot Technologies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$13.36 - $15.43 $417,192 - $481,832	31,227 New	31,227 $445,000
Q2 2022 Aug 09, 2022	SELL	$13.12 - $15.03 $93,545 - $107,163	-7,130 Reduced 45.5%	8,540 $119,000
Q1 2022 May 16, 2022	BUY	$13.54 - $15.35 $151,025 - $171,213	11,154 Added 246.99%	15,670 $224,000
Q4 2021 Feb 11, 2022	BUY	$13.17 - $16.4 $59,475 - $74,062	4,516 New	4,516 $61,000
Q3 2021 Nov 09, 2021	SELL	$16.3 - $17.26 $46,797 - $49,553	-2,871 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$16.55 - $18.64 $437,946 - $493,251	-26,462 Reduced 90.21%	2,871 $48,000
Q1 2021 May 14, 2021	BUY	$16.71 - $19.9 $490,154 - $583,726	29,333 New	29,333 $535,000
Q3 2019 Nov 12, 2019	SELL	$16.15 - $17.99 $121,464 - $135,302	-7,521 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$16.58 - $20.49 $124,698 - $154,105	7,521 New	7,521 $133,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.